Inflammatory bowel disease (IBD), with increasing incidence,
causes
a range of gastrointestinal symptoms and brings distress and impact
on the health and lives of patients. The aim of this study was to
explore the protective effects of industrially produced rice protein
peptides (RPP) on dextran sulfate sodium (DSS)-induced acute colitis
in mice and the potential mechanisms. The results showed that RPP
treatment alleviated the symptoms of colitis in mice, including weight
loss, colon shortening, and injury, decreased the level of disease
activity index (DAI), regulated the balance of inflammatory factors
and oxidation, activated Kelch-like ECH-associating protein 1 (Keap1)-nuclear
factor E2-related factor 2 (Nrf2) signaling pathway, regulated the
expression of related antioxidant proteases, and promoted the expression
of intestinal tight junction proteins. In addition, RPP maintained
intestinal mucosal barrier function and alleviated acute colitis caused
by DSS treatment in mice by increasing the value of F/B, increasing
the relative abundance of beneficial bacteria such as Akkermansia, and regulating the level of short-chain fatty acids. In conclusion,
RPP alleviated colitis symptoms through the Keap1–Nrf2 signaling
pathway and regulating gut microbiota, which had the potential as
dietary supplements or functional foods.